About Enzyme Engineering & Protein Design
The Enzyme Engineering & Protein Design category is part of the Synthetic Biology market map, tracking 12 companies building in this segment. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. Curated by Hartmann Capital's venture research team.
Companies in Enzyme Engineering & Protein Design
- Codexis — Public, $355M
- Novonesis — Public
- Arzeda — Series C, $65M
- Scindo — Seed, $5M
- Zymvol — Seed, $2M
- EvoEnzyme — Series A, $8M
- Pando Bioscience — Seed, $3M
- Colossal Biosciences — Series C, $435M
- BRAIN Biotech — Public
- Biomatter — Seed, $3M
- Baseimmune — Seed, $12M
- Enzymit — Seed, $5M
Frequently Asked Questions
- What companies are in the Enzyme Engineering & Protein Design category?
- The Enzyme Engineering & Protein Design category includes 12 companies: Codexis, Novonesis, Arzeda, Scindo, Zymvol, EvoEnzyme, Pando Bioscience, Colossal Biosciences, BRAIN Biotech, Biomatter, Baseimmune, Enzymit. This is part of the Synthetic Biology market map maintained by Hartmann Capital.
- How many Enzyme Engineering & Protein Design startups are tracked?
- Hartmann Capital tracks 12 companies in the Enzyme Engineering & Protein Design segment of the Synthetic Biology market map.
- What are the best funded Enzyme Engineering & Protein Design companies?
- Top funded companies in Enzyme Engineering & Protein Design include Colossal Biosciences ($435M), Codexis ($355M), Arzeda ($65M), Baseimmune ($12M), EvoEnzyme ($8M). Browse the full list in the Synthetic Biology market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.